Broadcom
AVGO
Alibaba
BABA
Adobe
ADBE
Apple
AAPL
Cisco
CSCO
US Stock MarketDetailed Quotes
CRNX Crinetics
- 53.920
- -0.020-0.04%
Close Dec 26 16:00 ET
- 53.920
- 0.0000.00%
Post 20:01 ET
5.00BMarket Cap-14.57P/E (TTM)
54.175High52.880Low392.07KVolume53.360Open53.940Pre Close21.08MTurnover0.43%Turnover RatioLossP/E (Static)92.74MShares62.53052wk High6.00P/B4.93BFloat Cap33.67052wk Low--Dividend TTM91.47MShs Float62.530Historical High--Div YieldTTM2.40%Amplitude10.630Historical Low53.774Avg Price1Lot Size
Crinetics News
Crinetics Pharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Addus Homecare (ADUS)
JMP Securities Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $87
JMP Securities Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $87
LifeSci Capital Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $82
Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (LXRX), Halozyme (HALO) and Crinetics Pharmaceuticals (CRNX)
LifeSci Capital Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $82
Promising Outlook for Crinetics Pharmaceuticals' Paltusotine in Phase 3 Trial Drives Buy Rating
Citi Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $74
Crinetics Pharmaceuticals Analyst Ratings
JonesTrading Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $71
Piper Sandler Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $97
Piper Sandler Remains a Buy on Crinetics Pharmaceuticals (CRNX)
Morgan Stanley Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $70
H.C. Wainwright Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $81
LifeSci Capital Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $82
Crinetics Pharmaceuticals: Advancing Cancer Treatment With Novel NDC Platform – A Buy Recommendation
LifeSci Capital Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $77
JonesTrading Maintains Crinetics(CRNX.US) With Buy Rating, Raises Target Price to $71
Piper Sandler Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $97
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.